Cesarean section rates statistics: the national number and the hospital variation behind it

She was 39 weeks, first baby, head down, no diabetes, no hypertension, no prior surgery. Her labor stalled at 6 centimeters for three hours on a Friday evening. The attending offered a cesarean. I was the covering physician on call. The chart was clean enough that either path was defensible. What changed the conversation was not her risk profile. It was which hospital she was in: a facility whose low-risk cesarean rate sat well above the national average.

That is the problem with cesarean section rates as a public statistic. The national number is clean enough for a reporter on deadline. The hospital number is what actually determines whether a low-risk first birth becomes major abdominal surgery.

In 2024, 32.4% of U.S. live births were delivered by cesarean section, according to final National Center for Health Statistics (NCHS) data published by the CDC. That is the citable national figure. Everything below is the context that number alone cannot carry: global benchmarks, the WHO 10-15% debate, low-risk (NTSV) variation, primary versus repeat surgery, VBAC access, outcome tradeoffs, racial disparities, and cost.

The U.S. cesarean rate

If you need one sentence for a national story, use this: in 2024, 32.4% of live births in the United States were cesarean deliveries, according to CDC/NCHS final data. In absolute terms, that is 1,173,391 cesareans and 2,450,519 vaginal deliveries.

The rate has been stuck near one-third of births for more than a decade. It peaked at 32.9% in 2009, drifted down to about 31.7% in 2019, and has climbed again since. NCHS provisional reporting for 2024 put the same overall figure at 32.4%, with the low-risk cesarean rate unchanged at 26.6%. Final 2024 FastStats confirm the 32.4% total. Provisional NCHS data for 2025 put the overall rate slightly higher still, at 32.5%, with the low-risk rate at 26.9%.

Primary cesarean delivery (a first cesarean among women who have not had one before) rose from 22.8% in 2023 to 22.9% in 2024, per NCHS Data Brief No. 535. That is a small annual move, but it matters because primary surgery is what feeds the next decade of repeat cesareans. Once a first cesarean is performed, subsequent births are far more likely to be surgical as well.

Roughly 3.63 million births were registered in the United States in 2024. At a 32.4% cesarean rate, surgical birth is no longer a specialty event. Cesarean delivery can be lifesaving. Placenta previa, uterine rupture, cord prolapse, and some fetal distress patterns leave no responsible alternative. The public-health problem is not that cesareans exist. It is that rates this high, with this much facility variation among similar patients, cannot be explained by medical necessity alone.

Global rates and the WHO benchmark

Globally, about 1 in 5 births (21.1%) is by cesarean, according to a 2021 WHO-linked analysis by Betran and colleagues in BMJ Global Health, covering data through 2018 from 154 countries. WHO summarized the same body of work in June 2021: worldwide cesarean use rose from about 7% in 1990 to 21%, and if trends hold, nearly 29% of births could be cesarean by 2030.

Regional extremes are stark. Sub-Saharan Africa sits near 5%, a figure that often reflects under-access rather than low need. Latin America and the Caribbean sit near 43%. Northern America was estimated around 32% in the same global series, consistent with U.S. vital statistics. In several countries, cesareans already outnumber vaginal births.

The WHO benchmark that journalists still cite (the idea that population cesarean rates should sit between 10% and 15%) dates to a 1985 expert panel. In 2015, WHO restated the evidence more carefully: when cesarean rates rise toward 10% across a population, maternal and newborn deaths fall; above about 10%, further increases are not associated with additional mortality reductions at the population level. WHO also shifted emphasis away from a single "ideal" hospital target and toward need-based care and better classification, including the Robson system.

That nuance is often lost. Critics of the 10-15% range argue that modern case mix (older mothers, higher BMI, more twins, better preterm survival) makes a 1985 threshold a blunt instrument. Some analyses suggest benefits may extend higher than 15%. The data here is weaker than headline writers want. What is not weak: rates above 30% in high-resource systems, with wide facility variation, are hard to defend as pure clinical need. The U.S. 32.4% figure is a useful global reference, not proof that half of American cesareans are unnecessary. The better domestic quality measure is the low-risk first-birth rate.

Low-risk NTSV rates and hospital variation

NTSV means nulliparous, term, singleton, vertex: first birth, full term (37 weeks or more), one baby, head-first. It is the group for whom cesarean is most often avoidable, and the measure used by the Joint Commission, Leapfrog, CMS, and Healthy People 2030.

In 2024, the U.S. low-risk cesarean rate was 26.6%, according to CDC reporting tied to provisional and final birth statistics. Healthy People 2030 set a target of 23.6% for low-risk women with no prior births (objective MICH-06). The most recent national figure sits above that target, and the objective is marked "getting worse."

Hospital-to-hospital variation is the story inside the national rate. A widely cited 2013 Health Affairs analysis by Kozhimannil, Law, and Virnig examined 2009 data from 593 U.S. hospitals and found overall cesarean rates ranging from 7.1% to 69.9%, roughly a tenfold spread. Even among lower-risk patients, variation was large. Patient risk does not explain gaps that wide.

More recent hospital reporting from the Leapfrog Group keeps the same theme. Leapfrog's 2025 maternity findings put the national average NTSV cesarean rate near 25.3% among reporting hospitals for the period covered, still above Leapfrog's standard of 23.6% (aligned with Healthy People 2030). State averages in that report ranged from about 18.8% in Nebraska to about 28.9% in Mississippi. One in five hospitals reported disparities between non-Hispanic Black and non-Hispanic White NTSV rates.

When two hospitals in the same metro area serve similar patients and post NTSV rates 10 percentage points apart, practice culture is doing work that physiology is not. Induction timing, labor-progress definitions, continuous versus intermittent monitoring norms, midwifery staffing, and the threshold for "failure to progress" all shift outcomes. So does the Friday-afternoon effect: the informal pressure to resolve a long labor before the weekend attending handoff.

For families planning pregnancy after infertility treatment, mode-of-delivery statistics interact with other risk factors. Our IVF due date calculator can help with dating, but dating alone does not determine surgical risk. Multiple gestation and advanced maternal age both raise cesarean probability; those cases should not be averaged away in a low-risk NTSV denominator.

Primary, repeat, and VBAC

Think of the cesarean rate as two linked engines. The first is the primary cesarean: surgery in a woman who has never had one. The second is the repeat cesarean among women with a uterine scar. U.S. primary rates near 23% keep the second engine fully fueled.

Vaginal birth after cesarean (VBAC) is the main off-ramp. In 2024, the U.S. VBAC rate was 15.5 per 100 live births to women with a previous cesarean, according to March of Dimes PeriStats using NCHS final natality data. In plain language: among women with a prior cesarean who gave birth again, about one in six delivered vaginally.

That is better than the mid-2000s trough, when VBAC fell below 10% after malpractice pressure and hospital policy retreats, but it remains far below what clinical success rates would support if access were broad. Among women who attempt a trial of labor after cesarean (TOLAC), published series commonly report successful vaginal birth in 60% to 80% of attempts, a range reflected in ACOG Practice Bulletin No. 205 and subsequent clinical reviews. The gap between a 60-80% success rate among those who try and a 15.5% VBAC rate among all prior-cesarean births is largely an access and counseling gap, not a biology gap.

Access is uneven. Many hospitals do not offer TOLAC because they cannot guarantee immediate emergency cesarean capability. Rural hospitals and maternity care deserts face this constraint most sharply; see our related coverage of maternity care deserts and provider shortages. ACOG supports TOLAC as a reasonable option for many women with one prior low-transverse cesarean, and often for carefully selected women with two, but facility readiness is non-negotiable. Uterine rupture risk with one prior low-transverse scar is generally under 1% in contemporary series, yet when rupture occurs, minutes matter.

For patients, the practical questions are concrete: Does this hospital allow VBAC? What is its VBAC success rate? Is anesthesia in-house 24 hours? Those answers do more work than a national percentage.

Outcomes and what surgery changes

Cesarean delivery reduces certain risks and raises others. The balance depends on indication. An emergency cesarean for cord prolapse is not clinically comparable to a scheduled repeat cesarean at 39 weeks in an otherwise healthy mother, and outcome studies that mix those scenarios can mislead.

For the mother, cesarean is major abdominal surgery. Short-term risks include hemorrhage requiring transfusion, wound infection, venous thromboembolism, and longer stays than uncomplicated vaginal birth. Longer term, each additional cesarean raises risk of placenta previa and placenta accreta spectrum, which drive severe morbidity and, in the worst cases, hysterectomy. That is why primary cesarean prevention is a maternal safety priority, not only a cost issue.

For the newborn, cesarean can protect a compromised fetus. It can also raise the risk of transient tachypnea when performed before labor, especially before 39 weeks. Population data do not show that lifting a high-resource country's rate from 25% to 35% improves mortality. That is the core of WHO's 2015 statement. Withholding indicated cesareans in low-resource settings kills women and babies. Overuse and underuse can coexist, sometimes in the same country stratified by zip code.

Cesarean birth also intersects with postpartum recovery and mental health. Longer pain, mobility limits, and birth experiences that feel like loss of control show up in postpartum depression risk profiles. For the broader mental health data, see our article on postpartum depression statistics. For severe maternal outcomes, cesarean is both a treatment for emergency hemorrhage and a contributor to surgical morbidity. That duality shows up in maternal mortality statistics and case reviews.

Pregnancy complications such as preeclampsia and gestational diabetes raise cesarean probability for legitimate clinical reasons. Those conditions have their own epidemiology; see pregnancy complications and preeclampsia statistics and gestational diabetes statistics. Adjusting for them still leaves a large residual of practice variation.

Racial disparities

Black women in the United States have the highest cesarean rates of any major racial and ethnic group tracked in national vital statistics. In 2024 final NCHS data, the cesarean delivery rate was 37.5% for non-Hispanic Black women, compared with 31.0% for non-Hispanic White women and 32.1% for Hispanic women. Asian women also sit above the White rate, at 34.4%.

Low-risk cesarean rates show a similar pattern. In 2024 final NCHS data, the low-risk cesarean rate for Black women was 31.5%, versus 25.5% for White women and 25.9% for Hispanic women. That means the disparity is not fully explained by higher rates of twins, preterm birth, or breech presentation. NTSV deliberately strips those factors out.

Some of the gap tracks higher rates of hypertension and obesity. Some tracks hospital of delivery: Black women are more likely to deliver in facilities with higher baseline cesarean rates. Residual disparities after clinical risk adjustment point to differences in decision-making and how "failure to progress" or fetal intolerance is interpreted. Leapfrog's finding that one in five hospitals report Black-White NTSV gaps inside the same facility is hard to dismiss as case mix. The disparity feeds future placental risk and recovery burden and sits alongside the Black-White gap in pregnancy-related death.

Cost differences

Cesarean birth costs more. A September 2025 Peterson-KFF Health System Tracker analysis of employer-sponsored insurance claims (2021-2023) estimated average pregnancy, delivery, and postpartum spending at about $28,998 for cesarean births versus $15,712 for vaginal births. Out-of-pocket averages were about $3,071 versus $2,563. The total-cost gap is large; the out-of-pocket gap is smaller because many families hit deductibles and out-of-pocket maximums either way.

Those figures are not pure "price of the incision." Cesarean episodes include longer stays and anesthesia, plus the higher chance of complicating conditions that led to surgery. Still, mode of delivery is one of the largest swing factors in maternity spending. Bundled payments and equalizing fees for vaginal and cesarean birth are among the non-clinical strategies WHO has highlighted. A medically indicated cesarean is worth the cost. An avoidable one is expensive twice: on the bill and in the next pregnancy, when a scarred uterus narrows options.

If you are still planning conception timing rather than a birth facility, tools such as our ovulation calculator and period calculator help with cycle timing. Once pregnancy is established, shift the research agenda toward hospital NTSV rates, VBAC policies, and 24/7 obstetric anesthesia. Those are the variables that actually shape mode of delivery.

Frequently asked questions about cesarean section rates

What is the current U.S. cesarean section rate?

According to CDC/NCHS final data for 2024, 32.4% of U.S. live births were cesarean deliveries (1,173,391 cesareans out of roughly 3.6 million births). The low-risk (NTSV) cesarean rate was 26.6% the same year. These are the standard national figures reporters cite from vital statistics.

What does the WHO say the cesarean rate should be?

Since 1985, many sources have cited a 10-15% population range. WHO's 2015 statement clarified that population rates above about 10% are not linked to further drops in maternal and newborn mortality. WHO now emphasizes need-based care over a single hospital target. The U.S. rate of 32.4% remains well above that classic benchmark.

What is an NTSV cesarean rate and why does it matter?

NTSV means first birth, term, singleton, head-down. It measures cesareans in a relatively low-risk group and is used by Healthy People 2030 (target 23.6%), Leapfrog, and the Joint Commission. Because this group should need surgery less often, hospital-to-hospital NTSV gaps are a better quality signal than the overall rate.

How common is VBAC after a previous cesarean?

In 2024, the U.S. VBAC rate was 15.5 per 100 live births to women with a prior cesarean, per March of Dimes analysis of NCHS data. Among women who attempt labor after cesarean, success rates in published series are typically 60-80% (ACOG). Access to trial of labor, not success when attempted, is the tighter bottleneck.

Are cesarean rates higher for Black women in the U.S.?

Yes. In 2024 NCHS final data, the cesarean rate was 37.5% for non-Hispanic Black women versus 31.0% for non-Hispanic White women and 32.1% for Hispanic women. Low-risk rates show a similar disparity (31.5% Black, 25.5% White, 25.9% Hispanic). Clinical risk, hospital of delivery, and inequitable care patterns all contribute; none fully erases the gap alone.

How much more does a cesarean cost than a vaginal birth?

Peterson-KFF analysis of employer plan claims found average pregnancy-through-postpartum spending of about $28,998 for cesarean versus $15,712 for vaginal delivery. Out-of-pocket costs averaged about $3,071 versus $2,563. Medicaid births have different patient cost-sharing, but facility costs still diverge by mode of delivery.